Learn about our Team

We are a team of dedicated business and scientific experts, ready to develope superior biopharmaceuticals. Our management has a proven track record in out-licensing the entire products to global pharmaceutical and biotech companies.

Claus Schalper, MBA, CEO
Managing Director, Founder

Claus started his career at Arthur Andersen and subsequently led two IT companies as CEO. He co-founded Pieris Pharmaceuticals, Inc. (Nasdaq: PIRS) with Prof. Dr. Arne Skerra in 2001 and was CFO until its listing in the US (2014). In 2009, he also served as CEO for Pieris, closing this Company`s Allergan deal as well as preparing for its strategic partnership with Sanofi.

Uli Binder, M.Sc., CTO
Chief Technology Officer, Founder

Uli Binder studied Molecular Biotechnology and Business Administration. He accomplished his Ph.D. studies at the Technical University of Munich and has extensive experience in protein engineering.

Arne Skerra, Ph.D., Professor
Chairman of the Board, Founder

Dr. Arne Skerra is Professor at the Technical University of Munich and a leading expert in therapeutic protein design. Beside PASylation®, he invented several other commercially successful technologies, such as bacterially produced antibody fragments, Anticalins® and the Strep-tag®.